brimonidine tartrate has been researched along with Pain in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balbaba, M; Çelebi, S; Ulaş, F | 1 |
| Levitt, JO; Routt, ET | 1 |
| Bervoets, K; Gobert, A; Le Marouille-Girardon, S; Millan, MJ; Renouard, A; Rivet, JM; Widdowson, P | 1 |
| Ahmadi, MA; Anderlini, P; Esmaeli, B; Kim, RY; Naderi, AA; Rivera, P | 1 |
1 trial(s) available for brimonidine tartrate and Pain
| Article | Year |
|---|---|
Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Cataract; Cloprostenol; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Middle Aged; Pain; Phacoemulsification; Postoperative Period; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Travoprost | 2013 |
3 other study(ies) available for brimonidine tartrate and Pain
| Article | Year |
|---|---|
Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33%.
Topics: Administration, Cutaneous; Adult; Brimonidine Tartrate; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Female; Follow-Up Studies; Gels; Humans; Pain; Quinoxalines; Recurrence; Risk Assessment; Rosacea; Sampling Studies; Severity of Illness Index | 2014 |
Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenaline.
Topics: Animals; Brimonidine Tartrate; Hippocampus; Male; Motor Activity; Norepinephrine; Pain; Quinoxalines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2 | 1994 |
Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation.
Topics: Acetazolamide; Bone Marrow Transplantation; Brimonidine Tartrate; Choroid Diseases; Drug Therapy, Combination; Graft vs Host Disease; Humans; Lymphoma, T-Cell; Male; Methylprednisolone; Middle Aged; Pain; Quinoxalines; Scleritis; Transplantation, Homologous | 2002 |